ENDOR AG/ DE0005491666 /
| 2024-11-12 7:50:03 PM | Chg. -0.001 | Volume | Bid7:50:06 PM | Ask7:50:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.010EUR | -9.52% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 69,741EUR | - | 0.02 |
GlobeNewswire
03-28
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
2020-05-01
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
2020-04-28
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
2020-04-24
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
2020-04-17
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
2020-03-02
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
2020-01-16
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
2020-01-16
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
